Ya-ling Wei
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
PRMT5-mediated methylation of LKB1 controls PD-L1 expression in NSCLC.
Journal: Biomedical journal
Published: March 22, 2026
SLC6A14 Drives Mitochondrial Fusion and Oxidative Phosphorylation to Promote Cancer Stemness and Early-Onset of Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 11, 2025
Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity.
Journal: International journal of biological sciences
Published: April 21, 2025
Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer.
Journal: Cell reports. Medicine
Published: January 10, 2025
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2.
Journal: Cell & bioscience
Published: December 11, 2022
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions.
Journal: Molecular therapy. Nucleic acids
Published: February 12, 2021
Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2.
Journal: Frontiers in pharmacology
Published: October 06, 2020
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs.
Journal: Oncogene
Published: August 05, 2020
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
Journal: Oncogene
Published: July 08, 2020
Incense burning smoke sensitizes lung cancer cells to EGFR TKI by inducing AREG expression.
Journal: American journal of cancer research
Published: February 06, 2018
MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.
Journal: Molecular oncology
Published: February 12, 2017
Last Updated: 09/26/2026